Triple nucleoside analogue vs. efavirenz-containing regimens for the initial
treatment of HIV infection: AIDS Clinical Trials Group (ACTG) Study A5095

RM Gulick; H Ribaudo; CM Shikuma; S Lustgarten; K Squires; WA Meyer; E Acosta; BR Schackman; CD Pilcher; RL Murphy; WE Maher; M Witt; RC Reichman; S Snyder; KL Klingman; DR Kurizkes; for the ACTG A5095 Protocol Team

Triple nucleoside analogue vs. efavirenz-containing regimens for the initial treatment of HIV infection: AIDS Clinical Trials Group (ACTG) Study A5095

RM Gulick, H Ribaudo, CM Shikuma, S Lustgarten, K Squires, WA Meyer, E Acosta, BR Schackman, CD Pilcher, RL Murphy, WE Maher, M Witt, RC Reichman, S Snyder, KL Klingman, DR Kurizkes, for the ACTG A5095 Protocol Team

Medicine, Infectious Diseases Division

Research output: Contribution to journal › Article

Original language	English (US)
Pages (from-to)	32-43
Number of pages	12
Journal	N Engl J Med
Issue number	350
State	Published - 2004

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Gulick, RM., Ribaudo, H., Shikuma, CM., Lustgarten, S., Squires, K., Meyer, WA., Acosta, E., Schackman, BR., Pilcher, CD., Murphy, RL., Maher, WE., Witt, M., Reichman, RC., Snyder, S., Klingman, KL., Kurizkes, DR., & Team, F. T. ACTG. A. P. (2004). Triple nucleoside analogue vs. efavirenz-containing regimens for the initial treatment of HIV infection: AIDS Clinical Trials Group (ACTG) Study A5095. N Engl J Med, (350), 32-43.

@article{1eb357d1debf43d7a1e73f02077fe6e3,

title = "Triple nucleoside analogue vs. efavirenz-containing regimens for the initial treatment of HIV infection: AIDS Clinical Trials Group (ACTG) Study A5095",

author = "RM Gulick and H Ribaudo and CM Shikuma and S Lustgarten and K Squires and WA Meyer and E Acosta and BR Schackman and CD Pilcher and RL Murphy and WE Maher and M Witt and RC Reichman and S Snyder and KL Klingman and DR Kurizkes and Team, {for the ACTG A5095 Protocol}",

year = "2004",

language = "English (US)",

pages = "32--43",

journal = "N Engl J Med",

number = "350",

}

Gulick, RM, Ribaudo, H, Shikuma, CM, Lustgarten, S, Squires, K, Meyer, WA, Acosta, E, Schackman, BR, Pilcher, CD, Murphy, RL, Maher, WE, Witt, M, Reichman, RC, Snyder, S, Klingman, KL, Kurizkes, DR & Team, FTACTGAP 2004, 'Triple nucleoside analogue vs. efavirenz-containing regimens for the initial treatment of HIV infection: AIDS Clinical Trials Group (ACTG) Study A5095', N Engl J Med, no. 350, pp. 32-43.

TY - JOUR

T1 - Triple nucleoside analogue vs. efavirenz-containing regimens for the initial treatment of HIV infection: AIDS Clinical Trials Group (ACTG) Study A5095

AU - Gulick, RM

AU - Ribaudo, H

AU - Shikuma, CM

AU - Lustgarten, S

AU - Squires, K

AU - Meyer, WA

AU - Acosta, E

AU - Schackman, BR

AU - Pilcher, CD

AU - Murphy, RL

AU - Maher, WE

AU - Witt, M

AU - Reichman, RC

AU - Snyder, S

AU - Klingman, KL

AU - Kurizkes, DR

AU - Team, for the ACTG A5095 Protocol

PY - 2004

Y1 - 2004

M3 - Article

SP - 32

EP - 43

JO - N Engl J Med

JF - N Engl J Med

IS - 350

ER -